Patents by Inventor Kevin MUNNELLY

Kevin MUNNELLY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR THE IN SITU DELIVERY OF THERAPEUTIC AND DIAGNOSTIC AGENTS
    Publication number: 20220049269
    Abstract: Synthetic minimal cells (SMC) are provided for delivering a therapeutic or diagnostic agent to a subject or to a site within a subject in need of treatment or diagnosis. SMCs may be targeted to the site or sense the site and initiate production and release of the therapeutic or diagnostic agent. SMCs comprise a sensor, at least one genetic circuit and outputting means to deliver the therapeutic agent.
    Type: Application
    Filed: September 23, 2019
    Publication date: February 17, 2022
    Applicant: SynLife, Inc.
    Inventors: Felix MOSER, Katarzyna ADAMALA, David BENJAMIN, Edward Stuart BOYDEN, Jeremy WERTHEIMER, Kevin MUNNELLY, Elazer EDELMAN